Anixa Biosciences, Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

3.605

-0.055 (-1.50%)

At close: Aug 26, 2026, 4:00 PM EDT

3.560

-0.045 (-1.25%)

Pre-market: Aug 27, 2026, 5:13 AM EDT

Anixa Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	-10.03	-10.93	-12.55	-9.81	-13.6	-12.95
Depreciation & Amortization	0.04	0.04	0.04	0.05	0.04	0.06
Loss (Gain) From Sale of Assets	-	-	-	-	-	-0.01
Loss (Gain) From Sale of Investments	0.01	-0.14	-	-	-	-
Stock-Based Compensation	3.23	3.81	4.8	4.74	6.75	8.06
Other Operating Activities	-0.09	-0.1	-0.14	-0.12	-0.18	-0.17
Change in Accounts Receivable	-0.06	0.17	0.1	-0.22	-0.03	-
Change in Accounts Payable	-0.03	-0.36	0.32	-0.06	0.13	-0.1
Change in Other Net Operating Assets	-0.18	0.34	0.11	-0.78	0.39	0.17
Operating Cash Flow	-7.12	-7.17	-7.34	-6.21	-6.49	-4.94
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Sale of Property, Plant & Equipment	-	-	-	-	-	0.04
Investment in Securities	1.47	4.87	4.28	-5.6	-10.73	-3.96
Investing Cash Flow	1.47	4.87	4.28	-5.6	-10.73	-3.92

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Issuance of Common Stock	5.32	2.39	3.42	0.37	0.45	31.57
Repurchase of Common Stock	-	-	-0.01	-	-	-
Other Financing Activities	-0.11	-0.11	-	-	-	-
Financing Cash Flow	5.21	2.28	3.42	0.37	0.45	31.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Cash Flow	-0.43	-0.03	0.36	-11.45	-16.77	22.71

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Free Cash Flow	-7.12	-7.17	-7.34	-6.21	-6.49	-4.94
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-	-	-	-2956.67%	-	-964.45%
Free Cash Flow Per Share	-0.21	-0.22	-0.23	-0.20	-0.21	-0.17
Levered Free Cash Flow	-3.64	-3.29	-3	-3.02	-1.26	0.04
Unlevered Free Cash Flow	-3.64	-3.29	-3	-3.02	-1.26	0.04

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Change in Working Capital	-0.27	0.15	0.53	-1.06	0.49	0.08

SEC Filings: 10-K · 10-Q